兴图新科(688081) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 26,415,603.28, representing a significant increase of 474.72% compared to the same period last year[4]. - Total operating revenue for Q1 2022 was CNY 26,415,603.28, a significant increase of 474.5% compared to CNY 4,596,270.25 in Q1 2021[19]. - Total operating costs for Q1 2022 were CNY 28,800,946.95, up from CNY 25,446,809.91 in Q1 2021, reflecting a year-over-year increase of 9.3%[19]. - Net profit for Q1 2022 was CNY -2,204,885.04, an improvement from CNY -19,487,443.11 in Q1 2021, indicating a reduction in losses[20]. - The net profit attributable to shareholders was a loss of CNY 1,871,361.67, with a net profit excluding non-recurring gains and losses also showing a loss of CNY 1,646,748.93[4]. - The basic and diluted earnings per share were both CNY -0.03, indicating a loss per share[5]. - The company reported a basic and diluted earnings per share of CNY -0.03 for Q1 2022, an improvement from CNY -0.26 in Q1 2021[21]. Cash Flow - The net cash flow from operating activities was negative at CNY -14,241,179.45, indicating a cash outflow during the quarter[5]. - The net cash flow from operating activities for Q1 2022 was CNY -14,241,179.45, compared to CNY -26,716,015.04 in Q1 2021, showing a decrease in cash outflow[23]. - Cash received from sales of goods and services in Q1 2022 was CNY 33,781,833.78, down from CNY 51,270,651.10 in Q1 2021[23]. - Total cash inflow from financing activities amounted to $1,470,000[25]. - Net cash flow from financing activities was $1,470,000[25]. - The net increase in cash and cash equivalents was -$39,805,710.67, compared to -$163,468,940.43 in the previous period[25]. - The beginning balance of cash and cash equivalents was $236,661,210.07, down from $375,699,408.93[25]. - The ending balance of cash and cash equivalents was $196,855,499.40, compared to $212,230,468.50 in the previous period[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 729,831,630.45, down 3.18% from the end of the previous year[5]. - Total assets decreased from RMB 753,779,472.71 to RMB 729,831,630.45, a reduction of about 3.17%[16]. - The company's total current assets decreased from RMB 576,442,537.14 as of December 31, 2021, to RMB 544,359,897.04 as of March 31, 2022, a decline of approximately 5.56%[15]. - Total current liabilities decreased from RMB 81,749,881.51 to RMB 57,891,787.30, a decrease of approximately 29.15%[16]. - The company reported a significant reduction in accounts payable from RMB 51,290,303.52 to RMB 31,758,613.05, a decline of about 38.06%[16]. - Total liabilities as of Q1 2022 were CNY 58,669,373.77, a decrease from CNY 82,207,020.99 in the previous year[20]. - The company's total equity as of Q1 2022 was CNY 671,162,256.68, slightly down from CNY 671,572,451.72 in Q1 2021[20]. Research and Development - Research and development (R&D) expenses totaled CNY 10,768,833.92, accounting for 40.77% of operating revenue, which is a decrease of 208.33 percentage points year-on-year[5]. - Research and development expenses for Q1 2022 were CNY 8,817,567.72, up from CNY 7,143,680.47 in Q1 2021, representing a 23.5% increase[20]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,125[11]. - The largest shareholder, Cheng Jiaming, holds 28,862,900 shares, representing 39.22% of total shares[11]. Other Financial Metrics - The weighted average return on net assets was -0.28%, reflecting a decrease of 2.43 basis points compared to the previous year[5]. - The company noted a substantial increase in other current liabilities by 251.14%, primarily due to a significant rise in the amount of tax to be transferred[9]. - The company experienced a 69.30% increase in prepayments, attributed to higher advance payments for goods[9]. - The company has ongoing development expenditures of RMB 8,241,599.94, up from RMB 6,290,333.74 in the previous period[16]. - The company has not reported any significant changes in its long-term liabilities[16]. - The company recorded other income of CNY 118,001.81 in Q1 2022, compared to CNY 151,755.18 in Q1 2021[20].